about
Antiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safetyShort-term and long-term treatment with propafenone: determinants of arrhythmia suppression, persistence of efficacy, arrhythmogenesis, and side effects in patients with symptoms.Stereoselective Inhibition of the hERG1 Potassium Channel.Effects of propafenone on 45Ca movements and contractile responses in vascular smooth muscleElectrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres.Effects on rabbit cardiac potentials of aprindine and indecainide, a new antiarrhythmic agent, in normoxia and hypoxia.Effects of 5-hydroxy-propafenone in guinea-pig atrial fibres.The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart.Cardiovascular effects of bevantolol, a selective beta 1-adrenoceptor antagonist with a novel pharmacological profileA sensitive quantitative assay for the determination of propafenone and two metabolites, 5-hydroxypropafenone and N-depropylpropafenone, in human K2EDTA plasma using LC-MS/MS with ESI operated in positive mode.Effects of propafenone on calcium currents in single ventricular myocytes of guinea-pig.Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trial.Anti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.Effects of propafenone on calcium current in guinea-pig ventricular myocytes.Effects of propafenone on electrical and mechanical activities of single ventricular myocytes isolated from guinea-pig hearts.Electrophysiological mechanism for the antiarrhythmic action of propafenone: a comparison with mexiletine.Therapeutic drug monitoring: antiarrhythmic drugsBevantolol: A Beta-1 Adrenoceptor Antagonist with Unique Additional Actions
P2860
Q26852003-FB07B4E4-CBC0-4A5E-BBD5-C1609E378EE0Q33612075-D1BEB78C-4C80-4810-B410-9B5C30120B79Q35155243-7B1212A3-B0DA-4362-A89D-13F5472F1BDCQ35871997-A826E029-835E-4BBB-BFE0-B6C129405FC3Q35886542-09CB1FBE-B00D-4DFB-A61E-CEABF4105675Q35886768-5FD11DE1-80C6-4275-9671-6EA62F2A724AQ35887480-B0C189C4-5CA7-490B-BDF2-88C9BD15F6C0Q35888619-ED50FEE4-13DF-45CB-97E2-FAB2694BC3F3Q36004546-C02C3157-24B2-4332-87D0-E7E996BD601FQ36297805-68DBE22C-146E-45A5-8CB9-7AEC95FB3961Q36329422-26BFBAD0-C953-4370-A62C-F2AFB9A56F5BQ37326986-8EB6ECDA-A6B0-4AD6-B9DE-E8519107218EQ37495803-4C0B153F-FA4B-419F-97EA-86C30AE0FF4FQ41831036-42617AC4-A4DE-4432-9E75-B5D6E8629B1EQ41839851-3525A027-A19C-4E3E-AE99-1B90AE7261FBQ42258751-B6526C44-081D-4F0F-B45B-FB0326C11ABBQ42780616-6FF5D0FC-FDC4-40F2-84B8-AD89FA3DB561Q57487964-EF42CFBA-A982-4839-BE90-EC631892972E
P2860
description
1984 nî lūn-bûn
@nan
1984 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
The multiple modes of action of propafenone.
@ast
The multiple modes of action of propafenone.
@en
The multiple modes of action of propafenone.
@nl
type
label
The multiple modes of action of propafenone.
@ast
The multiple modes of action of propafenone.
@en
The multiple modes of action of propafenone.
@nl
prefLabel
The multiple modes of action of propafenone.
@ast
The multiple modes of action of propafenone.
@en
The multiple modes of action of propafenone.
@nl
P1476
The multiple modes of action of propafenone.
@en
P2093
Vaughan Williams EM
P304
P356
10.1093/OXFORDJOURNALS.EURHEARTJ.A061621
P577
1984-02-01T00:00:00Z